|
March 5, 2018 Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com 1:27 Jazz Pharmaceuticals announces FDA acceptance of NDA for Solriamfetol (JZP-110) for excessive sleepiness associated with narcolepsy or obstructive sleep apnea https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-announces-fda-acceptance-of-nda-for-solriamfetol-jzp-110-for-excessive-sleepiness-associated-with-narcolepsy-or-obstructive-sleep-apnea-300607369.html 2:52 Mylan to introduce two new cost-saving HIV combination treatments in the US https://www.prnewswire.com/news-releases/mylan-to-introduce-two-new-cost-saving-hiv-combination-treatments-in-the-us-300607274.html 4:55 Biogen and AbbVie announce the voluntary worldwide withdrawal of marketing authorizations for ZINBRYTA® (daclizumab) for relapsing multiple sclerosis http://media.biogen.com/press-release/autoimmune-diseases/biogen%C2%A0and-abbvie-announce%C2%A0-voluntary%C2%A0worldwide-withdrawal-marketi https://www.medscape.com/viewarticle/893352 7:20 FDA warns of fraudulent and unapproved flu products https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm599223.htm Brought to you by Nascent Medical. For assistance with medical writing, please email info@nascentmc.com. Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/ |